7.71
1.32%
-0.09
전일 마감가:
$7.80
열려 있는:
$7.84
하루 거래량:
26,340
Relative Volume:
0.23
시가총액:
$142.91M
수익:
$62.81M
순이익/손실:
$-13.75M
주가수익비율:
-9.4024
EPS:
-0.82
순현금흐름:
$153.00K
1주 성능:
+6.90%
1개월 성능:
-7.71%
6개월 성능:
-39.35%
1년 성능:
-8.04%
Optimizerx Corp Stock (OPRX) Company Profile
명칭
Optimizerx Corp
전화
248-651-6558
주소
260 CHARLES STREET, WALTHAM, MI
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-02-02 | 재개 | B. Riley Securities | Buy |
2022-11-01 | 개시 | Stifel | Buy |
2022-07-15 | 개시 | SVB Leerink | Outperform |
2021-10-18 | 재개 | B. Riley Securities | Buy |
2021-04-13 | 개시 | RBC Capital Mkts | Outperform |
2019-01-03 | 개시 | William Blair | Outperform |
모두보기
Optimizerx Corp 주식(OPRX)의 최신 뉴스
OptimizeRx Co. (NASDAQ:OPRX) Shares Acquired by Rice Hall James & Associates LLC - MarketBeat
OptimizeRx expands pharma client engagement to $10M - Investing.com
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value - The Tech Outlook
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a - The Bakersfield Californian
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value - StockTitan
OptimizeRx Launches Novel Brand Eligibility Technology - Martechcube
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences - ForexTV.com
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences - StockTitan
Down -12.46% in 4 Weeks, Here's Why OptimizeRx (OPRX) Looks Ripe for a Turnaround - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $14.00 - Defense World
Vanguard Group Inc. Raises Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx (NASDAQ:OPRX) PT Lowered to $11.00 - Defense World
A Closer Look at 5 Analyst Recommendations For OptimizeRx - Benzinga
Earnings Release: Here's Why Analysts Cut Their OptimizeRx Corporation (NASDAQ:OPRX) Price Target To US$15.79 - Yahoo Finance
OptimizeRx Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance UK
Contrasting OptimizeRx (NASDAQ:OPRX) and Joint Stock Company Kaspi.kz (NASDAQ:KSPI) - Defense World
Earnings call: OptimizeRx reports solid growth, misses revenue target - Investing.com
OptimizeRx Corporation (NASDAQ:OPRX) Q2 2024 Earnings Call Transcript - Insider Monkey
OptimizeRx Corp. (OPRX) Tops Q2 Earnings Estimates - MSN
OptimizeRx Corp. (OPRX) Tops Q2 Earnings Estimates - Yahoo Canada Finance
OptimizeRx Reports Second Quarter 2024 Financial Results - StockTitan
Institutional investors may adopt severe steps after OptimizeRx Corporation's (NASDAQ:OPRX) latest 24% drop adds to a year losses - Yahoo Finance
Smith Micro Software, Inc. (SMSI) Reports Q2 Loss, Misses Revenue Estimates - Zacks Investment Research
OptimizeRx (OPRX) to Release Earnings on Thursday - MarketBeat
OptimizeRx Corp. (OPRX) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
OptimizeRx (OPRX) Set to Announce Quarterly Earnings on Thursday - Defense World
Acadian Asset Management LLC Cuts Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Analysts Issue Forecasts for OptimizeRx Co.'s Q3 2024 Earnings (NASDAQ:OPRX) - MarketBeat
Q3 2024 Earnings Estimate for OptimizeRx Co. (NASDAQ:OPRX) Issued By B. Riley - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Forecasted to Earn Q2 2024 Earnings of ($0.26) Per Share - Defense World
OptimizeRx Co. (NASDAQ:OPRX) to Post Q2 2024 Earnings of ($0.26) Per Share, B. Riley Forecasts - MarketBeat
OptimizeRx (NASDAQ:OPRX) Coverage Initiated by Analysts at B. Riley - MarketBeat
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET - ForexTV.com
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET - StockTitan
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET - EIN News
OptimizeRx Co. (NASDAQ:OPRX) Shares Acquired by BNP Paribas Financial Markets - Defense World
OptimizeRx adapts to US privacy laws for pharma marketing - Investing.com
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing ... - NRToday.com
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation - StockTitan
OptimizeRx adapts to US privacy laws for pharma marketing - Investing.com India
RPC (NYSE:RES) Shares Down 4% - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Receives $16.00 Average Target Price from Analysts - MarketBeat
Mirae Asset Global Investments Co. Ltd. Sells 3,278 Shares of MaxLinear, Inc. (NYSE:MXL) - Defense World
Mirae Asset Global Investments Co. Ltd. Reduces Position in Teekay Tankers Ltd. (NYSE:TNK) - Defense World
Mirae Asset Global Investments Co. Ltd. Invests $542,000 in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Mirae Asset Global Investments Co. Ltd. Sells 2,581 Shares of The Carlyle Group Inc. (NASDAQ:CG) - Defense World
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients - ForexTV.com
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients - StockTitan
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients – IT Business Net - IT Business Net
Essex Investment Management Co. LLC Takes $1.05 Million Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
VSee Health (NASDAQ:VSEE) Stock Quotes, Forecast and News Summary - Benzinga
Optimizerx Corp (OPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Optimizerx Corp 주식 (OPRX) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Spangler Patrick D | Director |
Jun 05 '24 |
Option Exercise |
0.00 |
10,061 |
0 |
32,181 |
Vos Ellen O'Connor | Director |
Jun 05 '24 |
Option Exercise |
0.00 |
10,061 |
0 |
49,488 |
WASSON GREGORY D | Director |
Jun 05 '24 |
Option Exercise |
0.00 |
10,061 |
0 |
34,029 |
HALAS GUS D | Director |
Jun 05 '24 |
Option Exercise |
0.00 |
10,061 |
0 |
80,926 |
Lang James Paul | Director |
Jun 05 '24 |
Option Exercise |
0.00 |
10,061 |
0 |
54,758 |
Silvestro Stephen L | Chief Commercial Officer |
May 02 '24 |
Option Exercise |
0.00 |
90,000 |
0 |
108,261 |
Silvestro Stephen L | Chief Commercial Officer |
Mar 01 '24 |
Option Exercise |
0.00 |
1,927 |
0 |
6,624 |
Odence-Ford Marion | General Counsel and CCO |
Mar 01 '24 |
Option Exercise |
0.00 |
771 |
0 |
14,499 |
Odence-Ford Marion | General Counsel and CCO |
Feb 11 '24 |
Option Exercise |
0.00 |
4,000 |
0 |
15,114 |
FEBBO WILLIAM J | CEO |
Jan 09 '24 |
Option Exercise |
0.00 |
9,628 |
0 |
481,028 |
자본화:
|
볼륨(24시간):